Switzerland· 62785003

Latuda

A lurasidone product containing lurasidonum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC N05AE05

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedLatudaATCN05AE05REGISTER NO.62785003PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Lurasidone is registered in 16 of 19 countries.

Countries holding a registration under ATC N05AE05 (lurasidone), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 9 of them publish a price we can compare per daily dose

Lurasidone · ATC N05AE05

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lurasidone costs, country by country.

Normalised to the WHO defined daily dose (60 mg), the median price runs from $2.63 in Italy to $6.45 in Switzerland — a ×2.4 gap.

  • Switzerland: $6.45 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Lurasidone · price per daily dose (60 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$6.45
  • IT Italy$2.63
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
lurasidonum
Manufacturer
—
Country
Switzerland (CH)
ATC code
N05AE05
ATC class
Lurasidone
Defined daily dose
60 mg, O
Swissmedic category
B
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680627850030
    28 Stk
    CHF 134.4

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

242 interactions on record for lurasidone.

Graded by severity as the source publishes them — 32 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Lurasidone · interactions on record

242 records

  • 32 severe
  • 205 moderate

Most severe, free to view

  • MetoclopramideA03FA01severe
  • AprepitantA04AD12severe
  • KetoconazoleH02CA03severe
  • ErythromycinJ01FA01severe

5 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lurasidone in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lurasidone products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Lurasidon G.L., Lurasidon Genericon
  • Bulgaria · Lurasidone Accord, Луразидон Тева
  • Czechia · Isaq, Lurasidon G.L. Pharma
  • Germany · Lurasidon Elpen
  • Denmark · Elgera, Lurasidone Accord
  • Spain · Lurasidona Cinfa, Lurasidona Tecnigen
  • Finland · Lurasidone Accord
  • United Kingdom (Northern Ireland) · Lurasidone Accord Healthcare, Lurasidone Amarox
  • Greece · Elgera, Latomno
  • Croatia · Lurasidon Teva
  • Iceland · Latuda
  • Italy · Lurasidone Accord, Lurasidone Doc
  • Liechtenstein · Latuda
  • Netherlands · Lurasidon Teva
  • Norway · Latuda, Lurasidone Accord
  • Poland · Alurazen, Asil
  • Portugal · Latomno, Lurasidona Farmoz
  • Sweden · Lurasidon G.L. Pharma, Lurasidone Accord
  • Slovenia · Lurasidon Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dd60a38d-771b-4138-aaed-afe95662b44a
GET /v1/drugs/dd60a38d-771b-4138-aaed-afe95662b44a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "lurasidoni hydrochloridum 80 mg",
  "valid_from": "2013-09-01",
  "limitations": "[{\"description\":\"Die Vergütung der einzelnen Dosisstärken erfolgt entsprechend der Zulassung indikationsabhängig gemäss Fachinformation:<br>\\nSchizophrenie: Latuda 40 mg und Latuda 80 mg<br>\\nBehandlung depressiver Episoden im Rahmen einer bipolaren Störung Typ 1: Latuda 20 mg und Latuda 40 mg <br>\\n<br>\\nEntstehen für die Behandlung depressiver Episoden im Rahmen einer bipolaren Störung Typ 1 aufgrund einer Dosisanpassung auf 60 mg (20 mg + 40 mg) die doppelten Kosten, sind die Kosten der jeweiligen Packungen Latuda 20 mg auf Basis FAP von der Medius AG demjenigen Krankenversicherer rückzuvergüten, bei dem die versicherte Person zum Zeitpunkt des Bezuges versichert war. Die MWSt kann nicht zusätzlich zum FAP zurückgefordert werden. Der Krankenversicherer fordert die Firma Medius AG zur Rückvergütung auf. Die Aufforderung zur Rückvergütung soll in der Regel innerhalb von drei Monaten nach Beendigung der Therapie erfolgen.<br>\\n\",\"costApproval\":null,\"indication\":\"20064.01\",\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2021-04-01\",\"validTo\":null}]",
  "galenic_form": "Filmtabl 80 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2013-09-01",
  "self_retention_pct": 10
}

See everything about lurasidone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.